Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The p53 protein is one of the best-known tumour suppressors. Recently discovered ASPP1 and ASPP2 are specific activators of p53. To understand, if apoptosis-stimulating protein of p53 (ASPP) inactivation offers a selective advantage to tumors that have wild-type p53, we measured the mRNA expression of ASPP1 and ASPP2 in tumor cell lines retaining wide-type p53. In addition, the CpG island methylation status of ASPP1 gene and ASPP2 gene in the 5'-untranslated region was also investigated in order to understand the possible cause of abnormal expression of ASPP1 and ASPP2 in the tumor cell lines retaining wide-type p53. The data showed that mRNA expression of ASPP1 and ASPP2 is downregulated and CpG island tested is hypermethylated. These results indicated that ASPP CpG island aberrant methylation could be one molecular and genetic alteration in wild-type p53 tumours.

Original publication

DOI

10.1016/j.febslet.2005.01.069

Type

Journal article

Journal

FEBS Lett

Publication Date

14/03/2005

Volume

579

Pages

1587 - 1590

Keywords

5' Untranslated Regions, Adaptor Proteins, Signal Transducing, Apoptosis, Apoptosis Regulatory Proteins, Base Sequence, Carrier Proteins, Cell Line, Tumor, CpG Islands, DNA Methylation, Down-Regulation, Gene Expression Regulation, Neoplastic, Humans, Molecular Sequence Data, RNA, Messenger, Transcriptional Activation, Tumor Suppressor Protein p53